Global Acne Medication Market to Grow at a CAGR of 4.2% During 2024-2032, Driven by the Rising Prevalence of Inflammatory Acne

In 2020, the inflammatory acne segment, among other acne types, held a significant share in the market. The symptoms of inflammatory acne include redness, swelling, and deeply blocked pores filled with debris, germs, and dead skin cells. The bacteria Propionibacterium acnes are responsible for turning non-inflammatory acne into inflamed acne. Propionibacterium colonises the sebaceous follicle route, causing redness and swelling as a result of an immunological response. The need for acne medication is expected to skyrocket because of the increased discomfort and scarring associated with inflammatory acne.

There has been increased competition among the key industry players, such as Bausch Health Companies Inc. (NYSE: BHC) and Galderma S.A., to strengthen their position and enhance the global reach. In April 2021, Galderma announced the launch of Aklief, a medication used to treat acne, in South Korea. This medicine targets the retinoid receptor gamma in the retinoic acid receptor (RAR) in the skin, making acne treatment more efficient and effective. This strategic decision will help the corporation develop its operations in South Korea. Such developments by the leading players are expected to significantly contribute to the market growth in the coming years.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Market Breakup by Therapeutic Class, Formulation, Type, Acne Type, Distribution Channel, and Region:

• Based on therapeutic class, the market is divided into retinoids, antibiotics, salicylic acid, benzoyl peroxide, and others.

• On the basis of formulation, the market is categorised into topical medications and oral medications.

• By type, the market is segmented into prescription medication and over-the-counter medication.

• The market is bifurcated based on acne type into non-inflammatory acne and inflammatory acne.

• Based on distribution channel, the market is divided into retail stores, pharmacies, and online.

• Geographically, the market is divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Key Findings of the Report:

• The increasing prevalence of acne disorders globally is driving the growth of the acne medication industry.

• The need for acne medicine is expected to skyrocket because of the increased discomfort and scarring associated with inflammatory acne.

• The rising popularity of retinoids is expected to favour the market growth in the forecast period.

• The new product launches by the manufacturers are expected to significantly contribute to the growth of the industry.

Key Offerings of the Report:

• The EMR report gives an overview of the global market for acne medication for the periods (2018-2023) and (2024-2032).

• The report also offers the historical (2018-2023) and forecast (2024-2032) markets for the therapeutic classes, formulations, types, acne types, distribution channels, and major regions of acne medication.

• The report analyses the market dynamics, covering the key demand and price indicators in the market, along with providing an assessment of the SWOT and Porter’s Five Forces models.

Almirall S.A, Bausch Health Companies Inc., GlaxoSmithKline plc., Johnson & Johnson Services, Inc., and Galderma S.A., among others are the key players in the global acne medication market. The EMR report looks into the capacity, market share, and latest developments of these major players like plant turnarounds, mergers and acquisitions, and capacity expansions.

About Us:

Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.

EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over a 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.

Contact Us:

Expert Market Research
Website: www.expertmarketresearch.com
Email: [email protected]
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790